Maccarrone, Mauro <br/><br/>
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism.  [electronic resource] 

 -  Journal of neurochemistry  May 2003 
 - 1018-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3042 
<br/><br/><label>Standard No.: </label>10.1046/j.1471-4159.2003.01759.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amidohydrolases--metabolism<br/>Animals<br/>Antiparkinson Agents--therapeutic use<br/>Arachidonic Acids--metabolism<br/>Binding, Competitive--drug effects<br/>Cannabinoid Receptor Modulators<br/>Cerebellum--drug effects<br/>Corpus Striatum--drug effects<br/>Cyclohexanols--pharmacokinetics<br/>Disease Models, Animal<br/>Endocannabinoids<br/>Excitatory Postsynaptic Potentials--drug effects<br/>Fatty Acids, Unsaturated--metabolism<br/>Glutamic Acid--metabolism<br/>Glycerides--metabolism<br/>In Vitro Techniques<br/>Levodopa--therapeutic use<br/>Oxidopamine<br/>Parkinsonian Disorders--chemically induced<br/>Patch-Clamp Techniques<br/>Phospholipase D--metabolism<br/>Polyunsaturated Alkamides<br/>Rats<br/>Rats, Wistar<br/>Receptors, Cannabinoid<br/>Receptors, Drug--agonists